Last reviewed · How we verify
Thiamin
At a glance
| Generic name | Thiamin |
|---|---|
| Sponsor | Hospital Sao Domingos |
| Target | Thiamin pyrophosphokinase 1, Thiamine transporter 1, Thiamine-triphosphatase |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Approved indications
- Cobalamin deficiency
- Korsakoff's psychosis
- Mineral Deficiency Prevention
- Mineral deficiency
- Pernicious anemia
- Prevention of Vitamin B12 Deficiency
- Thiamin deficiency
- Vitamin Deficiency Prevention
- Vitamin deficiency
Common side effects
Key clinical trials
- Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers (PHASE1)
- The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease (EARLY_PHASE1)
- Iron and Immune Response to Vaccine (IRONMUM) (NA)
- Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome (NA)
- Type 2 Diabetes and Blood Brain Barrier Improvement (EARLY_PHASE1)
- Clinical Trial On The Effect Of Artisterol On Risk Factors In Individuals With Suboptimal Cholesterol Levels (NA)
- Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial (NA)
- A Clinical Study to Evaluate the Efficacy of a Nutritional Supplement to Improve Carotenoid Content as Measured by a Non-invasive Hyperspectral Absorption Device (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |